News

RheumaGen CEO Richard Freed Presented at 2024 CBSA Biotech Symposium

RheumaGen CEO Richard Freed was invited to speak on the “Transformative Innovations in Colorado Advancing Regenerative Medicine” panel at the 2024 Biotech Symposium: Innovations in Regenerative Medicine on Tuesday, April 23, 2024. Freed highlighted the shifting landscape in regenerative medicine, saying, “We can use words like ‘cures’ now. We can see the future, and it’s really exciting for all of us.”

Learn more here.

Contact Us

    Media inquiries: RheumaGen@argotpartners.com

    Dedicated to Patients in Need

    RheumaGen was founded to relieve the burden that individuals suffering from autoimmune diseases have carried for so long. Mindful also of our own family members who are patients, we are not interested in incremental improvements. We seek cures; we seek remission.

    Learn Our Story